Efficacy and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Measure Up 1, Measure Up 2, and AD Up Phase 3 Clinical Trials at 52 Weeks

被引：0

作者：

Paller, Amy ^{[1
]}

Mendes-Bastos, Pedro ^{[2
]}

Eichenfield, Lawrence ^{[3
,4
,5
]}

Soong, Weily ^{[6
]}

Lio, Peter ^{[7
]}

Prajapati, Vimal ^{[8
,9
,10
]}

Platt, Andrew ^{[11
]}

Liu, John ^{[11
]}

Ladizinski, Barry ^{[11
]}

Thyssen, Jacob

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA

[2] Hosp CUF Descobertas, Dermatol Ctr, Lisbon, Portugal

[3] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Div Pediat & Adolescent Dermatol, San Diego, CA USA

[4] Univ Calif San Diego, Sch Med, Dept Dermatol, San Diego, CA USA

[5] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA USA

[6] AllerVie HealthAlabama Allergy & Asthma Ctr & Cli, Birmingham, AL USA

[7] Med Dermatol Associates Chicago, Chicago, IL USA

[8] Univ Calgary, Div Dermatol, Dept Med, Calgary, AB, Canada

[9] Univ Calgary, Sect Community Pediat, Dept Pediat, Calgary, AB, Canada

[10] Univ Calgary, Sect Pediat Rheumatol, Calgary, AB, Canada

[11] AbbVie Inc, N Chicago, IL USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

43049

引用

页码：AB157 / AB157

页数：1

共 50 条

[1] Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase 3 clinical trials at 52 weeks
Paller, Amy S.
Mendes-Bastos, Pedro
Eichenfield, Lawrence F.
Soong, Weily
Lio, Peter
Prajapati, Vimal H.
Platt, Andrew M.
Raymundo, Eliza
Liu, John
Ladizinski, Barry
Thyssen, Jacob P.
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[2] Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: a subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase III clinical trials
Paller, A. S.
Mendes-Bastos, P.
Eichenfield, L. F.
Soong, W.
Lio, P.
Prajapati, V. H.
Platt, A. M.
Teixeira, H. D.
Liu, J.
Ladizinski, B.
Thyssen, J. P.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E128 - E129
[3] Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials
Paller, Amy S.
Ladizinski, Barry
Mendes-Bastos, Pedro
Siegfried, Elaine
Soong, Weily
Prajapati, Vimal H.
Lio, Peter
Thyssen, Jacob P.
Simpson, Eric L.
Platt, Andrew M.
Raymundo, Eliza M.
Liu, Jianzhong
Calimlim, Brian M.
Huang, Xiaohong
Gu, Yihua
Hu, Xiaofei
Yang, Yang
Su, John C.
Zheng, Min
Yamamoto-Hanada, Kiwako
Teixeira, Henrique D.
Irvine, Alan D.
JAMA DERMATOLOGY, 2023, 159 (05) : 526 - 535
[4] Upadacitinib in moderate-to-severe atopic dermatitis: Combined safety analysis of phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
Guttman-Yassky, Emma
Irvine, Alan D.
Silverberg, Jonathan I.
Papp, Kim A.
Paller, Amy S.
Waterhouse, Brian
Tenorio, Allan R.
Ladizinski, Barry
Chu, Alvina D.
Liu, John
Reich, Kristian
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB129 - AB129
[5] Upadacitinib in moderate-to-severe atopic dermatitis: combined safety analysis of phase III studies (Measure Up 1, Measure Up 2 and AD Up)
Guttman-Yassky, Emma
Irvine, A. D.
Silverberg, J. I.
Papp, K. A.
Paller, A. S.
Waterhouse, B.
Tenorio, A. R.
Ladizinski, B.
Chu, A. D.
Liu, J.
Reich, Kristian
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E123 - E124
[6] Ef-ficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD UpRandomized Clinical Trials
Paller, Amy. S.
JAMA DERMATOLOGY, 2024, 160 (05) : 582 - 582
[7] Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials
Simpson, Eric L.
Papp, Kim A.
Blauvelt, Andrew
Chu, Chia-Yu
Hong, H. Chih-Ho
Katoh, Norito
Calimlim, Brian M.
Thyssen, Jacob P.
Chiou, Albert S.
Bissonnette, Robert
Gold, Linda F. Stein
Wegzyn, Colleen
Hu, Xiaofei
Liu, Meng
Liu, John
Tenorio, Allan R.
Chu, Alvina D.
Guttman-Yassky, Emma
JAMA DERMATOLOGY, 2022, 158 (04) : 404 - 413
[8] The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies
Cather, Jennifer
Magnolo, Nina
Cameron, Michael
Calimlim, Brian
Lane, Michael
Hays, Stephanie
Gamelli, Amy
Woo, Yu Ri
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[9] Rapid skin improvement with upadacitinib with or without topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
Simpson, Eric L.
Warren, Richard B.
Eichenfield, Lawrence F.
Katoh, Norito
Hu, Xiaofei
Zeng, Jiewei
Calimlim, Brian M.
Tenorio, Allan R.
Teixeira, Henrique D.
De Bruin-Weller, Marjolein
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB167 - AB167
[10] Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Jonathan I. Silverberg
Melinda J. Gooderham
Amy S. Paller
Mette Deleuran
Christopher G. Bunick
Linda F. Stein Gold
DirkJan Hijnen
Brian M. Calimlim
Wan-Ju Lee
Henrique D. Teixeira
Xiaofei Hu
Shiyu Zhang
Yang Yang
Ayman Grada
Andrew M. Platt
Diamant Thaçi
American Journal of Clinical Dermatology, 2024, 25 : 485 - 496

← 1 2 3 4 5 →